Relief for Difficult to Treat Menstrual Migraine and Migraine in Women Using Oral Contraceptives
AstraZenecaSAN ANTONIO, Texas-October 22, 1997- Results of clinical trials for ZOMIG (zolmitriptan), an investigational oral medication for the treatment of acute migraine, demonstrate that the compound may provide relief of migraine headache associated with and without menstruation, as well as migraine in women using oral contraceptives. These clinical trial data were presented at the American Osteopathic Association Research Conference, held October 19-23 in San Antonio. ZOMIG is a product of Zeneca Pharmaceuticals.